Photo Credit: Terriana
The following is a summary of “Implementation of a Cardiovascular Implantable Electronic Device Heart Failure Prediction Tool-Guided Management Pathway: CIED-Guided Heart Failure Management,” published in the October 2024 issue of Cardiology by Kratka et al.
Cardiovascular implantable electronic devices (CIEDs) can monitor physiological variables to identify subacute heart failure (HF) decompensation and impending heart failure hospitalization (HFH).
Researchers conducted a prospective study to implement an algorithm predicting HF hospitalization risk.
They predicted HF risk categories from scheduled (every 30 days) and unscheduled remote transmissions from 358 patients across 2 cardiology clinics (1/18/24-4/19/24), contacting patients with high risk for assessment and intervention.
The results showed that among 358 patients with 1,140 remote transmissions, 72 (20%) had at least 1 high-risk categorization. Of these, 67 (93%) were successfully contacted, with 34 (51%) reporting no HF symptoms, 24 (36%) experiencing mild to moderate symptoms, and 2 (3%) exhibiting severe symptoms. Clinical action was taken for 46 (69%) of these patients, including a diuretic intervention for 28 (42%) and adjustments to guideline-directed medical therapy for 12 (18%).
They concluded that clinicians successfully intervened in over 2-3rd of patients identified as high-risk for HF decompensation through remote monitoring data.
Source: ajconline.org/article/S0002-9149(24)00710-0/abstract
